CD34 and hydrops fetalis: In a study of Kakzanov et al., no difference in number of CD34+ cells was found in patients with HF with reduced ejection fraction (HFrEF) and in patients with HF with preserved ejection fraction (HFpEF), despite the fact that in a group of patients with HFrEF significantly more patients had ischemic heart disease [17].